CIK 0001835022 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Coya Therapeutics, Inc.
Sign in to watch- Ticker
- COYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650.739.3939
- Business address
- 12645 MEMORIAL DR., SUITE F1 #305, HOUSTON, TX, 77024
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Open-market buy Chief Financial Officer bought 1,800 shares at $7.19 ($12,934)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $7.36 ($36,797)
- 4 Open-market buy Chief Medical Officer bought 2,710 shares at $7.37 ($19,973)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $7.34 ($36,689)
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 5 of 12 · 232 filings